Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters

被引:25
作者
Kitaoka, Y
Kitawaki, J
Koshiba, H
Inoue, S
Ishihara, H
Teramoto, M
Honjo, H
机构
[1] Kyoto Prefectural Univ Med, Dept Obstet & Gynecol, Kamigyo Ku, Kyoto 6028566, Japan
[2] Akashi City Hosp, Dept Obstet & Gynecol, Akashi, Hyogo 6738501, Japan
关键词
aromatase cytochrome P450; estrogen receptor; progesterone receptor; uterine sarcoma; prognosis;
D O I
10.1016/j.jsbmb.2003.11.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the immunohistochemical expression of aromatase cytochrome P450 (P450arom), estrogen receptor (ER), progesterone receptor (PR), and Ki-67 in postoperative uterine sarcomas (n = 31) and the corresponding eutopic endometria (n = 20) to evaluate the relationships between the endocrine character of uterine sarcomas and the clinical features. In sarcoma tissues, P450arom was detected in 55% of cases, ER in 42%. PR in 42%, and Ki-67 in 90%. In eutopic endometria, P450arom was detected in 60% of cases, ER in 60%, and PR in 35%. There were correlations in the steroid-related proteins between the tumors and endometria (P = 0.001-0.026). The positivity of endometrial P450arom (P = 0.04) and ER (P = 0.006) was higher in surviving patients than dead patients regardless of the menstrual state. The results demonstrate correlation between the expression of P450arom, ER, and PR in tumors and eutopic endometria. Intense expression of the steroid-related proteins was associated with better survival. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 23 条
[1]   CYP19 (AROMATASE CYTOCHROME-P450) GENE-EXPRESSION IN HUMAN-MALIGNANT ENDOMETRIAL TUMORS [J].
BULUN, SE ;
ECONOMOS, K ;
MILLER, D ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1831-1834
[2]   EXPRESSION OF THE CYP19 GENE AND ITS PRODUCT AROMATASE CYTOCHROME-P450 IN HUMAN UTERINE LEIOMYOMA TISSUES AND CELLS IN CULTURE [J].
BULUN, SE ;
SIMPSON, ER ;
WORD, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03) :736-743
[3]   Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas [J].
Ishihara, H ;
Kitawaki, J ;
Kado, N ;
Koshiba, H ;
Fushiki, S ;
Honjo, H .
FERTILITY AND STERILITY, 2003, 79 :735-742
[4]  
JAMES V H T, 1987, Steroids, V50, P269, DOI 10.1016/0039-128X(83)90077-6
[5]  
Kitawaki J, 1996, ANTICANCER RES, V16, P91
[6]   Expression or aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium [J].
Kitawaki, J ;
Noguchi, T ;
Amatsu, T ;
Maeda, K ;
Tsukamoto, K ;
Yamamoto, T ;
Fushiki, S ;
Osawa, Y ;
Honjo, H .
BIOLOGY OF REPRODUCTION, 1997, 57 (03) :514-519
[7]   Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis [J].
Kitawaki, J ;
Kusuki, I ;
Koshiba, H ;
Tsukamoto, K ;
Fushiki, S ;
Honjo, H .
FERTILITY AND STERILITY, 1999, 72 (06) :1100-1106
[8]   AN ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR QUANTITATION OF AROMATASE CYTOCHROME-P-450 [J].
KITAWAKI, J ;
YOSHIDA, N ;
OSAWA, Y .
ENDOCRINOLOGY, 1989, 124 (03) :1417-1423
[9]   MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors [J].
Mittal, K ;
Demopoulos, RI .
HUMAN PATHOLOGY, 2001, 32 (09) :984-987
[10]   ENDOMETRIAL STROMAL SARCOMA EXPRESSION OF ESTROGEN-RECEPTORS, PROGESTERONE RECEPTORS AND ESTROGEN-INDUCED SRP27 (24K) SUGGESTS HORMONE RESPONSIVENESS [J].
NAVARRO, D ;
CABRERA, JJ ;
LEON, L ;
CHIRINO, R ;
FERNANDEZ, L ;
LOPEZ, A ;
RIVERO, JF ;
FERNANDEZ, P ;
FALCON, O ;
JIMENEZ, P ;
PESTANO, J ;
DIAZCHICO, JC ;
DIAZCHICO, BN .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :589-596